Torthaí cuardaigh - William D. Tap

Beachtaigh na torthaí
  1. 1
    MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action

    MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action de réir Neeta Somaiah, William D. Tap

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Locally Aggressive Connective Tissue Tumors

    Locally Aggressive Connective Tissue Tumors de réir Mrinal M. Gounder, David M. Thomas, William D. Tap

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Trametinib in Histiocytic Sarcoma with an Activating <i>MAP2K1</i> (MEK1) Mutation

    Trametinib in Histiocytic Sarcoma with an Activating <i>MAP2K1</i> (MEK1) Mutation de réir Mrinal M. Gounder, David B. Solit, William D. Tap

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities

    Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities de réir Jennifer L. Anderson, Christopher T. Denny, William D. Tap, Noah Federman

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    The Multidisciplinary Management of Osteosarcoma

    The Multidisciplinary Management of Osteosarcoma de réir Noah Federman, Nicholas M. Bernthal, Fritz C. Eilber, William D. Tap

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Sarcoma Immunotherapy: Past Approaches and Future Directions

    Sarcoma Immunotherapy: Past Approaches and Future Directions de réir Sandra P. D’Angelo, William D. Tap, Gary K. Schwartz, Richard D. Carvajal

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought

    CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought de réir Mary E. Klein, Marta Kovatcheva, Lara E. Davis, William D. Tap, Andrew Koff

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    The clinical heterogeneity of round cell sarcomas with <i><scp>EWSR1</scp>/<scp>FUS</scp></i> gene fusions: Impact of gene fusion type on clinical features and outcome

    The clinical heterogeneity of round cell sarcomas with <i><scp>EWSR1</scp>/<scp>FUS</scp></i> gene fusions: Impact of gene fusion type on clinical features and outcome de réir Yusuke Tsuda, Lei Zhang, Paul A. Meyers, William D. Tap, John H. Healey, Cristina R. Antonescu

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Psychosocial Needs and Preferences for Care among Adolescent and Young Adult Cancer Patients (Ages 15–39): A Qualitative Study

    Psychosocial Needs and Preferences for Care among Adolescent and Young Adult Cancer Patients (Ages 15–39): A Qualitative Study de réir Viswatej Avutu, Kathleen Lynch, Marie Barnett, Jacqueline Vera, Julia Glade Bender, William D. Tap, Thomas M. Atkinson

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma

    MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma de réir Emily K. Slotkin, Parag P. Patwardhan, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, William D. Tap, Gary K. Schwartz

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Evaluation of neoadjuvant therapy and histopathologic response in primary, high‐grade retroperitoneal sarcomas using the sarcoma nomogram

    Evaluation of neoadjuvant therapy and histopathologic response in primary, high‐grade retroperitoneal sarcomas using the sarcoma nomogram de réir Timothy R. Donahue, Michael W. Kattan, Scott D. Nelson, William D. Tap, Frederick R. Eilber, Fritz C. Eilber

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study

    Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopatholog... de réir Josephine K. Dermawan, Sinchun Hwang, Leonard H. Wexler, William D. Tap, Samuel Singer, Chad Vanderbilt, Cristina R. Antonescu

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Correlation Between Glycolytic Phenotype and Tumor Grade in Soft-Tissue Sarcomas by <sup>18</sup>F-FDG PET

    Correlation Between Glycolytic Phenotype and Tumor Grade in Soft-Tissue Sarcomas by <sup>18</sup>F-FDG PET de réir Matthias Benz, Sarah Dry, Fritz C. Eilber, Martin Allen-Auerbach, William D. Tap, David Elashoff, Michael E. Phelps, Johannes Czernin

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs

    Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs de réir Parag P. Patwardhan, Oliver Surriga, Michael J. Beckman, Elisa de Stanchina, Ronald P. DeMatteo, William D. Tap, Gary K. Schwartz

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

    Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign de réir Matthias Benz, Johannes Czernin, Sarah Dry, William D. Tap, Martin Allen-Auerbach, David Elashoff, Michael E. Phelps, Wolfgang Weber, Fritz C. Eilber

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets

    Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets de réir Evan Rosenbaum, Bhumika Jadeja, Bin Xu, Lei Zhang, Narasimhan P. Agaram, William D. Travis, Samuel Singer, William D. Tap, Cristina R. Antonescu

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    The epigenomics of sarcoma

    The epigenomics of sarcoma de réir Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, Jamie Yu, C. David Allis, William D. Tap, Marc Ladanyi, Torsten O. Nielsen

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    BCOR upregulation in a poorly differentiated synovial sarcoma with <i>SS18L1‐SSX1</i> fusion—A pathologic and molecular pitfall

    BCOR upregulation in a poorly differentiated synovial sarcoma with <i>SS18L1‐SSX1</i> fusion—A pathologic and molecular pitfall de réir Yu‐Chien Kao, Yun‐Shao Sung, Lei Zhang, Samuel Kenan, Samuel Singer, William D. Tap, David Swanson, Brendan C. Dickson, Cristina R. Antonescu

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    ATRX is a regulator of therapy induced senescence in human cells

    ATRX is a regulator of therapy induced senescence in human cells de réir Marta Kovatcheva, Will Liao, Mary E. Klein, Nicolas Robine, Heather Geiger, Aimeé M. Crago, Mark A. Dickson, William D. Tap, Samuel Singer, Andrew Koff

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma

    Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma de réir Josephine K. Dermawan, Sarah Chiang, Samuel Singer, Bhumika Jadeja, Martee L. Hensley, William D. Tap, Sujana Movva, Robert G. Maki, Cristina R. Antonescu

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: